| Literature DB >> 21922169 |
Joris C Verster1, Thomas Roth.
Abstract
RATIONALE: There are various methods to examine driving ability. Comparisons between these methods and their relationship with actual on-road driving is often not determined.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21922169 PMCID: PMC3285752 DOI: 10.1007/s00213-011-2484-0
Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN: 0033-3158 Impact factor: 4.530
Fig. 1A model of driving behavior according to Rasmussen and Michon. Experienced drivers operate at the gray-scaled diagonal of Fig. 2, whereas novice drivers operate in the upper right corner of the figure
Fig. 2Blood alcohol concentration (BAC) at which more than half of tests showed significant impairment (Moskowitz and Fiorentino 2000)
Difference scores from placebo for the tracking test and divided attention test
| Treatment |
| ΔSDLP | Tracking test | Divided attention test | |||
|---|---|---|---|---|---|---|---|
| Easy | Hard | Tracking | RT | Errors (%) | |||
| Zolpidem (20 mg) | 30 | +10.41a | 0.694** | 0.602** | 0.660** | 0.599** | 0.445* |
| Alprazolam (1 mg) | 18 | +9.62a | 0.447 | 0.875** | 0.693** | 0.372 | −0.025 |
| Zolpidem (10 mg) | 30 | +3.35a | 0.245 | 0.387* | 0.250 | 0.348 | 0.282 |
| Diphenhydramine (50 mg, day 1) | 48 | +2.74a | 0.252 | 0.285* | 0.255 | 0.012 | 0.238 |
| Oxycodone/paracetamol (10/650 mg) | 18 | +1.87 | 0.246 | 0.630** | 0.496* | 0.262 | 0.280 |
| Diphenhydramine (50 mg, day 4) | 48 | +1.56a | −0.133 | 0.031 | 0.224 | −0.166 | 0.014 |
| Alcohol (BAC = 0.05%) | 29 | +1.03a | 0.185 | 0.072 | 0.065 | 0.298 | 0.295 |
| Bromfenac (50 mg) | 18 | +0.51 | 0.225 | 0.241 | 0.092 | 0.056 | 0.337 |
| Levocetirizine (5 mg, day 4) | 48 | +0.46 | 0.167 | 0.330* | 0.397** | 0.187 | 0.286* |
| Zaleplon (10 mg) | 30 | −0.45 | 0.229 | 0.201 | 0.442* | 0.265 | 0.031 |
| Zaleplon (20 mg) | 30 | +0.43 | 0.039 | 0.292 | 0.079 | 0.289 | −0.176 |
| Levocetirizine (5 mg, day 1) | 48 | +0.22 | 0.029 | 0.459** | 0.229 | 0.263 | 0.025 |
| Oxycodone/paracetamol (5/325 mg) | 18 | −0.65 | 0.598** | 0.719** | 0.536* | 0.286 | 0.257 |
| Bromfenac (25 mg) | 18 | −0.66 | 0.545* | 0.415 | 0.539* | 0.109 | −0.050 |
| Overall | 491 | +2.09 | 0.412** | 0.444** | 0.470** | 0.420** | 0.219** |
|
|
|
|
|
| |||
RT reaction time, SDLP standard deviation of lateral position, N number of subjects
*p < 0.05, **p < 0.01; significance of correlation
aSDLP differed significantly from placebo
Difference scores from placebo for parameters of the Sternberg memory scanning test and DSST
| Treatment |
| ΔSDLP | Sternberg memory scanning | DSST | |
|---|---|---|---|---|---|
| RT | Errors (%) | ||||
| Zolpidem (20 mg) | 30 | +10.41a | 0.713** | 0.344 | −0.623** |
| Alprazolam (1 mg) | 18 | +9.62a | 0.510* | 0.391 | N/D |
| Zolpidem (10 mg) | 30 | +3.35a | 0.333 | 0.256 | 0.034 |
| Diphenhydramine (50 mg, day 1) | 48 | +2.74a | 0.156 | 0.412** | N/D |
| Oxycodone/paracetamol (10/650 mg) | 18 | +1.87 | 0.375 | 0.276 | N/D |
| Diphenhydramine (50 mg, day 4) | 48 | +1.56a | 0.050 | −0.093 | N/D |
| Alcohol (BAC = 0.05%) | 29 | +1.03a | 0.261 | 0.050 | −0.070 |
| Bromfenac (50 mg) | 18 | +0.51 | −0.071 | 0.247 | N/D |
| Levocetirizine (5 mg, day 4) | 48 | +0.46 | 0.055 | −0.225 | N/D |
| Zaleplon (10 mg) | 30 | −0.45 | 0.308 | −0.300 | −0.267 |
| Zaleplon (20 mg) | 30 | +0.43 | 0.326 | −0.106 | −0.148 |
| Levocetirizine (5 mg, day 1) | 48 | +0.22 | 0.046 | −0.155 | N/D |
| Oxycodone/paracetamol (5/325 mg) | 18 | −0.65 | 0.349 | 0.313 | N/D |
| Bromfenac (25 mg) | 18 | −0.66 | 0.193 | 0.113 | N/D |
| Overall | 491 | +2.09 | 0.435** | 0.150** | −0.396** |
|
|
|
| |||
RT reaction time, SDLP standard deviation of lateral position, DSST digit symbol substitution test, N number of subjects, N/D test was not included in test battery
*p < 0.05, **p < 0.01; significance of correlation
aSDLP differed significantly from placebo
Results from the stepwise regression analysis to determine which test parameters predict changes in SDLP
| Model | Included variables |
|
| Adjusted | Significance |
|---|---|---|---|---|---|
| 1 | Tracking divided attention test | 0.470 | 0.221 | 0.219 |
|
| 2 | Tracking divided attention test | 0.531 | 0.282 | 0.279 |
|
| RT Sternberg memory scanning test | |||||
| 3 | Tracking divided attention test | 0.562 | 0.316 | 0.311 |
|
| RT Sternberg memory scanning test | |||||
| Tracking (hard condition) | |||||
| 4 | Tracking divided attention test | 0.578 | 0.334 | 0.327 |
|
| RT Sternberg memory scanning test | |||||
| Tracking (hard condition) | |||||
| Error percent Sternberg memory scanning test | |||||
| 5 | Tracking divided attention test | 0.585 | 0.342 | 0.334 |
|
| RT Sternberg memory scanning test | |||||
| Tracking (hard condition) | |||||
| Error percent Sternberg memory scanning test | |||||
| RT divided attention test |
RT reaction time